{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:57:32Z","timestamp":1789073852011,"version":"build-2803163510"},"reference-count":23,"publisher":"Georg Thieme Verlag KG","issue":"12","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gesundheitswesen"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Hintergrund und Ziel Benzodiazepine und Z-Substanzen werden in erheblichem\n                    Umfang auf Privatrezept auch f\u00fcr gesetzlich Krankenversicherte\n                    verordnet, mit ehemals gro\u00dfen Unterschieden zwischen Ost- und\n                    Westdeutschland. Ziel der vorliegenden Studie ist es zu untersuchen, ob diese\n                    Unterschiede auch heute noch bestehen.<\/jats:p>\n                  <jats:p>Methode Die Sekund\u00e4rdatenanalyse nutzte anonymisierte\n                    Verordnungsdaten von niedergelassenen Haus\u00e4rzten, Neurologen und\n                    Psychiatern. Eingeschlossen wurden gesetzlich Krankenversicherte mit mindestens\n                    einer Verordnung eines Benzodiazepins oder einer Z-Substanz zwischen 2014 und\n                    2020. Unterschiede zwischen Ost- und Westdeutschland im Anteil der\n                    Privatverordnungen waren zentrales Outcome. In multiplen Regressionsanalysen\n                    wurde gepr\u00fcft, ob die Faktoren Region (Ost- vs. Westdeutschland) und\n                    Facharztgruppe (Haus\u00e4rzte vs. Neurologen\/Psychiatern)\n                    statistisch signifikante Pr\u00e4diktoren f\u00fcr den Anteil an\n                    Privatverordnungen sind \u2013 unter Ber\u00fccksichtigung der Alters- und\n                    Geschlechtszusammensetzung der Patienten einer Praxis.<\/jats:p>\n                  <jats:p>Ergebnisse Aus 867 Praxen wurden 2.200.446 Verordnungen von Z-Substanzen,\n                    Benzodiazepin-Anxiolytika und Benzodiazepin-Hypnotika\/Sedativa\n                    ausgewertet. \u00dcber 38% dieser Verordnungen wurden in Form von\n                    Privatrezepten ausgestellt; in Ostdeutschland lag der Anteil bei 53,6%,\n                    in Westdeutschland bei 34,8%. F\u00fcr Z-Substanzen war der Anteil an\n                    Privatverordnungen besonders hoch (70,7% in Ost- und 43,0% in\n                    Westdeutschland). Haus\u00e4rzte griffen weit h\u00e4ufiger als Neurologen\n                    und Psychiater zu Privatverordnungen. Der Anteil von Privatverordnungen stieg im\n                    Untersuchungszeitraum an, vergleichsweise stark in den westlichen\n                    Bundesl\u00e4ndern (von 33% auf 39%), geringf\u00fcgig in\n                    den \u00f6stlichen Bundesl\u00e4ndern (von 53% auf 54%).\n                    Im multivariaten Modell waren die Region (Ost\/West) und die\n                    Facharztgruppe \u00e4hnlich starke Pr\u00e4diktoren f\u00fcr das\n                    Ausma\u00df an Privatverordnungen, besonders bei Z-Substanzen.<\/jats:p>\n                  <jats:p>Schlussfolgerung Entgegen einer allgemeinen Angleichung von\n                    Lebenserwartung, Morbidit\u00e4tsrisiken und Gesundheitsverhalten in Ost- und\n                    Westdeutschland gibt es, trotz Ann\u00e4herung, weiterhin einen deutlichen\n                    Unterschied zwischen beiden Regionen im Anteil an Privatverordnungen bei\n                    Benzodiazepinen, speziell bei Z-Substanzen. Die Arztgruppen, die\n                    ma\u00dfgeblich diese Substanzen verordnen, n\u00e4mlich Neurologen und\n                    Psychiater auf der einen, Haus\u00e4rzte auf der anderen Seite unterscheiden\n                    sich ebenfalls erheblich in der Quote ihrer Privatrezepte f\u00fcr diese\n                    Substanzen.<\/jats:p>","DOI":"10.1055\/a-2160-2679","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T18:33:33Z","timestamp":1702319613000},"page":"1213-1219","source":"Crossref","is-referenced-by-count":6,"title":["Privatverordnungen von Benzodiazepinen und Z-Substanzen in Ost- und\n                    Westdeutschland \u2013 eine Sekund\u00e4rdatenanalyse"],"prefix":"10.1055","volume":"85","author":[{"given":"Thomas","family":"Grimmsmann","sequence":"additional","affiliation":[{"name":"Referat Arzneimittel und Methoden, Medizinischer Dienst\n                    Mecklenburg-Vorpommern, Schwerin, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Himmel","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Allgemeinmedizin, Universit\u00e4tsmedizin\n                    G\u00f6ttingen, Gottingen, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia\n                    in Adults: An American Academy of Sleep Medicine Clinical Practice\n                    Guideline","volume":"13","author":"M J Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.3399\/bjgp16X685213","article-title":"Benzodiazepine and z-hypnotic prescribing for older people in primary care: a\n                    cross-sectional population-based study","volume":"66","author":"C F Johnson","year":"2016","journal-title":"Br J Gen Pract"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited--will we ever learn?","volume":"106","author":"M Lader","year":"2011","journal-title":"Addiction"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/jsr.12594","article-title":"European guideline for the diagnosis and treatment of insomnia","volume":"26","author":"D Riemann","year":"2017","journal-title":"J Sleep Res"},{"key":"ref5","volume-title":"Arzneiverordnungs-Report","author":"U Schwabe","year":"2020"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e00896","DOI":"10.1002\/prp2.896","article-title":"Long-term benzodiazepines and z-drug prescribing in Australian general practice\n                    between 2011 and 2018: A national study","volume":"10","author":"A Woods","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/fampra\/cmz018","article-title":"General practitioners\u2019 concepts on issuing out-of-pocket prescriptions\n                    for hypnotics and sedatives in Germany","volume":"36","author":"K Schmalstieg-Bahr","year":"2019","journal-title":"Fam Pract"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"w13745","DOI":"10.4414\/smw.2013.13745","article-title":"Perceptions of German GPs on benefits and risks of benzodiazepines and\n                    Z-drugs","volume":"143","author":"F Hoffmann","year":"2013","journal-title":"Swiss Med Wkly"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3238\/arztebl.m2022.0151","article-title":"The Role of Private Prescriptions in Benzodiazepine and Z-Drug Use","volume":"119","author":"T Grimmsmann","year":"2022","journal-title":"Dtsch Arztebl Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3238\/arztebl.2015.0001","article-title":"The problems of long-term treatment with benzodiazepines and related\n                    substances","volume":"112","author":"K Janhsen","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/pds.2013","article-title":"Regional variations of private prescriptions for the non-benzodiazepine\n                    hypnotics zolpidem and zopiclone in Germany","volume":"19","author":"F Hoffmann","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5414\/cp203320%E2%80%A9","article-title":"Basic characteristics and representativeness of the German Disease Analyzer\n                    database","volume":"56","author":"W Rathmann","year":"2018","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/pds.3825","article-title":"Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven\n                    European electronic healthcare databases: a cross-national descriptive study\n                    from the PROTECT-EU Project","volume":"25","author":"C Huerta","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00103-021-03299-9","article-title":"30 Jahre Deutsche Einheit: Errungenschaften und verbliebene Unterschiede in der\n                    Mortalit\u00e4tsentwicklung nach Alter und Todesursachen","volume":"64","author":"P Grigoriev","year":"2021","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung\n                    Gesundheitsschutz"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.25646\/6077","article-title":"30 years after the fall of the Berlin Wall: Regional health differences in\n                    Germany","volume":"4","author":"T Lampert","year":"2019","journal-title":"J Health Monit"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/YIC.0000000000000393","article-title":"Antidepressant drug use and regional prescribing patterns in Germany: results\n                    from a large population-based study","volume":"37","author":"M D\u00f6rks","year":"2022","journal-title":"Int Clin Psychopharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00127-009-0067-8","article-title":"Prevalence of depression diagnosis and prescription of antidepressants in East\n                    and West Germany: an analysis of health insurance data","volume":"45","author":"A Bramesfeld","year":"2010","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1055\/s-2004-827169","article-title":"Public attitudes towards psychotropic drugs: have there been any changes in\n                    recent years?","volume":"37","author":"M C Angermeyer","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1055\/s-0034-1369995","article-title":"Privat statt Kasse? Einstellungen von Haus\u00e4rzten und Apothekern zur\n                    Verordnung von Hypnotika","volume":"139","author":"F Hoffmann","year":"2014","journal-title":"Dtsch Med Wochenschr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/imj.12315","article-title":"Twenty-year trends in benzodiazepine dispensing in the Australian\n                    population","volume":"44","author":"M M Islam","year":"2014","journal-title":"Intern Med J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5536","article-title":"Role of private prescriptions in the long-term use of benzodiazepines and\n                    Z-drugs: A patient-related follow-up study","author":"T Grimmsmann","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3122\/jabfm.2011.01.100268","article-title":"The complexity of family medicine care","volume":"24","author":"M A Bowman","year":"2011","journal-title":"J Am Board Fam Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3122\/jabfm.2011.01.100057","article-title":"Family medicine outpatient encounters are more complex than those of cardiology\n                    and psychiatry","volume":"24","author":"D Katerndahl","year":"2011","journal-title":"J Am Board Fam Med"}],"container-title":["Das Gesundheitswesen"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2160-2679.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T06:15:58Z","timestamp":1730787358000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2160-2679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,11]]},"published-print":{"date-parts":[[2023,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2160-2679","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0941-3790","1439-4421"],"issn-type":[{"value":"0941-3790","type":"print"},{"value":"1439-4421","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}